PMI Reports Third Quarter Financial Results for 2022

Oct.21.2022
PMI Reports Third Quarter Financial Results for 2022
Philip Morris International reported a 1.1% decline in Q3 net income, with 30.1% of revenue coming from smoke-free products.

Phimo International has released its third quarter 2022 and year-to-date performance report, revealing that PMI's net income has declined by 1.1% in Q3.


In the third quarter, the net revenue from smoke-free products accounted for 30.1% of the total net revenue. The market share of IQOS, a heated tobacco device (HTU), increased by 1.3 percentage points to 7.7% in the IQOS market. At the end of the quarter, the estimated total number of IQOS users was around 19.5 million (an increase of 3.6 million or 22% compared to September 30, 2021), of which about 13.5 million have switched to IQOS and quit smoking. The company will increase its quarterly dividend by 1.6% to $1.27 per share, or $5.08 per share on an annual basis.


For the first nine months of this year, the net income from new tobacco accounted for 30.4% of the total net income. HTU's market share in the IQOS market has increased by 1.2 percentage points to 7.6%.


Jacek Olczak, CEO of PMI, stated in a press release that the company achieved strong performance in the third quarter, despite pressures related to currency, supply chains, and inflation. Adjusted earnings per share for the quarter reached $1.53.


During this quarter, IQOS has continued to experience positive momentum, as the number of heated tobacco units and market share has increased in all major regions, partially due to the strong performance of ILUMA upon initial release. Furthermore, the strong performance of our combustible tobacco product portfolio has supplemented this trend, reflecting stable shipment volumes and encouraging growth in international market share and pricing acceleration.


Due to our strong performance from the beginning of the year, we have raised the lower end of our full-year adjusted net income growth outlook to between 6.5% and 8%, with organic growth. Additionally, we expect adjusted earnings per share to increase by 10% to 12% for the year, excluding currency.


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of its contents. The translation of this article is solely for industry-related communication and research purposes.


Due to limitations in translation ability, the translated article may vary in expression compared to the original. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macau, Taiwan, or international issues, 2FIRSTS aligns fully with the stance of the Chinese government.


Compilation of information is subject to the copyright of the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
Report says illegal vapes “threaten UK high streets” as 55% of councils seized thousands last year
Report says illegal vapes “threaten UK high streets” as 55% of councils seized thousands last year
The latest annual Illegal Vapes and Nicotine Product Report says nearly 5 million illegal vapes have been seized over the last three years—equivalent to three seized every minute—with a street value of £39m (USD equivalent not provided in the source; exchange-rate basis not stated). It says 1.3 million were seized last year and that 55% of UK council areas seized thousands of illegal products over the year.
Feb.26 by 2FIRSTS.ai
Finnish Customs Investigate Firm Suspected of Importing and Selling Nicotine Pouches Without Paying Tobacco Tax
Finnish Customs Investigate Firm Suspected of Importing and Selling Nicotine Pouches Without Paying Tobacco Tax
Finnish Customs are investigating a firm suspected of importing and selling nicotine pouches without paying tobacco tax. Two Finnish citizens have been questioned as part of the probe. The authority believes the nicotine pouches were imported into Finland from other EU countries before being distributed to Finnish retailers.
Mar.11 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10